EU Health Data Space May Speed Up R&D Through Access To Multi-Omics & Clinical Record Data

The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.

The European Health Data Space will help EU companies be more innovative and agile (Shutterstock)

More from Clinical Trials

More from Real-World Evidence